In Vitro Characterization of Pluronic F127 and D‐α‐Tocopheryl Polyethylene Glycol 1000 Succinate Mixed Micelles as Nanocarriers for Targeted Anticancer‐Drug Delivery
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Mixed micelles of Pluronic F127 and d‐α‐tocopheryl polyethylene glycol 1000 succinate (TPGS) in different molar ratios (10 : 0, 7 : 3, 5 : 5, and 3 : 7) were prepared to characterize this system as nanocarriers for targeted delivery of chemotherapeutic agents. Their size, zeta potential, critical micelle concentration, drug loading content, entrapment efficiency, drug release, cytotoxicity, and stability in serum were evaluated in vitro by using doxorubicin as the model anticancer drug. The micellar sizes ranged from 25 to 35 nm. The 7 : 3 and 5 : 5 micellar combinations had lower critical micelle concentrations (5 × 10−5 M) than the 10 : 0 combination (5 × 10−4 M). The entrapment efficiencies of the 7 : 3, 5 : 5, and 3 : 7 micellar combinations were 72%, 88%, and 69%, respectively. Doxorubicin release was greater at acidic tumour pH than at normal physiological pH. The doxorubicin‐loaded mixed micelles showed greater percent inhibition and apoptosis activity in human breast adenocarcinoma (MCF‐7) and acute monocytic leukaemia (THP‐1) cell lines than free doxorubicin did. The mixed micelles were also stable against aggregation and precipitation in serum. These findings suggest that Pluronic F127‐TPGS mixed micelles could be used as nanocarriers for targeted anticancer‐drug delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910 · cited 1×
“The use of nanocarriers such as: nanoparticles [5, 6], liposomes [7, 8], nanospheres [9–11], and polymeric micelles [12–15] is another strategy for increasing the efficacy of chemotherapeutic drugs.”
BackgroundBlock copolymer micelles: preparation, characterization and application in drug delivery
Gaucher, G., Dufresne, M.-H., Sant, V. P., Kang, N., Maysinger, D., & Leroux, J.-C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.034 · Cited by 1,498 · cited 1×
“Micelles can become disrupted by the presence of serum proteins [34].”
BackgroundPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 2×
“These findings are in agreement with previous reports [15, 21].”
BackgroundResultPhase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602204 · Cited by 623
The distribution of the anticancer drug Doxorubicin in relation to blood vessels in solid tumors
Primeau, A. J., Rendon, A., Hedley, D., Lilge, L., & Tannock, I. F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1664 · Cited by 499
Plummer, R., Wilson, R. H., Calvert, H., Boddy, A. V., Griffin, M., Sludden, J., Tilby, M. J., Eatock, M., Pearson, D. G., Ottley, C. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.6 · Cited by 390
Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., Muro, K., Yamada, Y., Okusaka, T., Shirao, K., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603855 · Cited by 290 · cited 1×
“Some successful micellar nanocarriers have been studied in different phases of clinical trials [16–19].”
Background
Cited by
Amphiphiles Self-Assembly: Basic Concepts and Future Perspectives of Supramolecular Approaches
Lombardo, D., Kiselev, M. A., Magazù, S., & Calandra, P. (2015) · Advances in Condensed Matter Physics · doi:10.1155/2015/151683 · Cited by 530
Polymeric mixed micelles as nanomedicines: Achievements and perspectives
Cagel, M., Tesan, F. C., Bernabeu, E., Salgueiro, M. J., Zubillaga, M. B., Moretton, M. A., & Chiappetta, D. A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.12.019 · Cited by 417
Vadlapudi, A. D., Cholkar, K., Vadlapatla, R. K., & Mitra, A. K. (2014) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2013.0157 · Cited by 62
Patel, A., Patel, M., Saha, N., Patel, S., Ahlawat, P., & Dharamsi, A. (2022) · Recent Advances in Drug Delivery and Formulation · doi:10.2174/2667387816666220128123737 · Cited by 6
Metadata
- Authors
- Butt, A. M., Amin, M. C. I. M., Katas, H., Sarisuta, N., Witoonsaridsilp, W., & Benjakul, R.
- Venue
- Journal of Nanomaterials
- Publisher
- Wiley
- Published
- 2012-01
- Volume
- 2012
- Issue
- 1
- ISSN
- 1687-4110 (ISSN-L)
- 1687-4129
- OpenAlex
- W2112805076
- Cited by
- 82
- References
- 8
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In Vitro Characterization of Pluronic F127 and D‐α‐Tocopheryl Polyethylene Glycol 1000 Succinate Mixed Micelles as Nanocarriers for Targeted Anticancer‐Drug Delivery. https://app.cochat.ai/papers/10.1155/2012/916573
- The paper
- Butt, A. M., Amin, M. C. I. M., Katas, H., Sarisuta, N., Witoonsaridsilp, W., & Benjakul, R. (2012). In Vitro Characterization of Pluronic F127 and D‐α‐Tocopheryl Polyethylene Glycol 1000 Succinate Mixed Micelles as Nanocarriers for Targeted Anticancer‐Drug Delivery. Journal of Nanomaterials. https://doi.org/10.1155/2012/916573
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.